Larvol Delta - Alzheimer39s-Disease-Pivotal-Trial-Design-for-Zervimesine-Following-an-End-of-Phase-2-Meeting-with-FDA

Elayta (zervimesine) - Cognition Therap

https://www.ctad-alzheimer.com/sites/www.ctad-alzheimer.com/files/medias/documents/Poster%20list_0112.pdf

Jennifer IACI 1; Michael GRUNDMAN 2,3; Nash HERNANDEZ 4; Anthony CAGGIANO 1

Dec 14, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next